Dr Timothy Steel

Article originally published by NeuroNews ‘Upstream’ causes of health inequities related to stroke—such as structural racism and conditions of the places where people live, learn,…

Article originally published by NeuroNews The EMBOTRAP® family of revascularisation devices (CERENOVUS) is innovative within the stent retriever space due to its differentiated design based on…

Article originally published by NeuroNews A systematic review and analysis published in the journal Interventional Neuroradiology has examined how far along “the right path” management paradigms for…

Article originally published by SpinalNews SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented…

Article originally published by NeuroNews While a number of companies in the neurovascular space have become increasingly focused on the ‘first-pass effect’ in mechanical thrombectomy treatments, many…

Article originally published by Neuronews. A recently published Cochrane review has concluded that the clinical benefits of spinal cord stimulation (SCS) do not outweigh the risks and…

Article originally published by Neuronews. A nationwide study drawing on data from Swedish patients has indicated that—while the majority of ruptured intracranial aneurysm patients treated…

Article originally published by Neuronews. A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre…

Article originally published by Neuronews. ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralised clinical trial with a small, non-invasive neuromodulation device for the…

Article originally published by Neuronews. Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone…